NanoVation Therapeutics, a Vancouver company co-founded by biotech magnate Pieter Cullis, has struck a partnership with ...

A California biotechnology company that helps doctors detect genetic causes for cancer is among those that could be cut out ...

The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032.

Ginkgo Datapoints embodies Ginkgo's mission of making biology easier to engineer by unlocking the full potential of AI in ...

Integrated biotech group ALPS Global Holding Bhd, which is en route to a Nasdaq listing in the fourth quarter of 2024, aims ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...

Ginkgo Bioworks Holdings Inc, based in Boston, Massachusetts, specializes in cell programming to revolutionize the production of various products. By manipulating cells, they create novel ...

The company has not yet had a commercial drug product utilizing ... of $13.7 million for Applied DNA Sciences, which may be considered relatively small within the biotech industry.

Explore Estonia’s biotech scene with 7 pioneering companies across Tallinn, Tartu, and beyond, fueled by top science parks ...

The company has not yet had a commercial drug product utilizing PCR-produced ... market capitalization of $13.7 million for Applied DNA Sciences, which may be considered relatively small within the ...

STONY BROOK, NY / ACCESSWIRE / September 17, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced it has received a ...